These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 38170219)
21. The Role of Adverse Pregnancy Outcomes in Conventional Cardiovascular Risk Prediction. Reddy SM; Wiecha N; Nguyen CT; Barch DH Matern Child Health J; 2023 Oct; 27(10):1774-1786. PubMed ID: 37280462 [TBL] [Abstract][Full Text] [Related]
22. High-sensitivity C-reactive protein use in cardiovascular risk screening at 6 to 12 months postpartum following hypertensive disorders of pregnancy. Johnstone AM; Pudwell J; Ackerman-Banks CM; Lundsberg LS; Lipkind HS; Smith GN Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100776. PubMed ID: 36273813 [TBL] [Abstract][Full Text] [Related]
23. Fatty acid-binding protein 4 predicts gestational hypertension and preeclampsia in women with gestational diabetes mellitus. Li B; Yang H; Zhang W; Shi Y; Qin S; Wei Y; He Y; Yang W; Jiang S; Jin H PLoS One; 2018; 13(2):e0192347. PubMed ID: 29394285 [TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcomes in women with previous gestational hypertension: A cohort study to guide counselling and management. Nzelu D; Dumitrascu-Biris D; Hunt KF; Cordina M; Kametas NA Pregnancy Hypertens; 2018 Apr; 12():194-200. PubMed ID: 29113718 [TBL] [Abstract][Full Text] [Related]
25. Pregnancy As a Predictor of Maternal Cardiovascular Disease: The Era of CardioObstetrics. Wu P; Mamas MA; Gulati M J Womens Health (Larchmt); 2019 Aug; 28(8):1037-1050. PubMed ID: 31408425 [TBL] [Abstract][Full Text] [Related]
26. Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors. Riise HKR; Sulo G; Tell GS; Igland J; Egeland G; Nygard O; Selmer R; Iversen AC; Daltveit AK Int J Cardiol; 2019 May; 282():81-87. PubMed ID: 30773269 [TBL] [Abstract][Full Text] [Related]
27. The long-term risk of cardiovascular disease among women with a history of hypertensive disorders of pregnancy: a systematic review of clinical practice guidelines. Atkinson J; Simpson G; Walker SP; Tong S; Hastie R; Lindquist A BMC Cardiovasc Disord; 2023 Sep; 23(1):443. PubMed ID: 37689661 [TBL] [Abstract][Full Text] [Related]
28. Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies. Chen KH; Chen LR Int J Med Sci; 2020; 17(4):543-548. PubMed ID: 32174785 [No Abstract] [Full Text] [Related]
29. Barriers and facilitators of cardiovascular disease prevention services for women with prior gestational diabetes or hypertensive disorders of pregnancy in low-income, middle-income and high-income settings: a scoping review protocol. Quansah DY; Visintini S; O'Neill C; Savard K; Lewis R; Coutinho T; Mullen KA BMJ Open; 2024 Aug; 14(8):e084212. PubMed ID: 39153794 [TBL] [Abstract][Full Text] [Related]
30. Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia. Aziz F; Khan MF; Moiz A Sci Rep; 2024 Mar; 14(1):6182. PubMed ID: 38486097 [TBL] [Abstract][Full Text] [Related]
31. Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies? Hermes W; Koopmans CM; van Pampus MG; Franx A; Bloemenkamp KW; van der Post J; Porath M; Tamsma JT; Mol BW; de Groot CJ Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):30-4. PubMed ID: 24011382 [TBL] [Abstract][Full Text] [Related]
32. Assessing knowledge of healthcare providers concerning cardiovascular risk after hypertensive disorders of pregnancy: an Australian national survey. Roth H; Homer CSE; Arnott C; Roberts L; Brown M; Henry A BMC Pregnancy Childbirth; 2020 Nov; 20(1):717. PubMed ID: 33228597 [TBL] [Abstract][Full Text] [Related]
33. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Parikh NI; Gonzalez JM; Anderson CAM; Judd SE; Rexrode KM; Hlatky MA; Gunderson EP; Stuart JJ; Vaidya D; Circulation; 2021 May; 143(18):e902-e916. PubMed ID: 33779213 [TBL] [Abstract][Full Text] [Related]
34. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Kramer CK; Campbell S; Retnakaran R Diabetologia; 2019 Jun; 62(6):905-914. PubMed ID: 30843102 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM). Walentowicz-Sadlecka M; Domaracki P; Sadlecki P; Siodmiak J; Grabiec M; Walentowicz P; Moliz MTA; Odrowaz-Sypniewska G Dis Markers; 2019; 2019():5870239. PubMed ID: 31481983 [TBL] [Abstract][Full Text] [Related]
37. Experiences with an integrated screening programme targeted at women who had a hypertensive disorder or diabetes in pregnancy in the Netherlands: a qualitative study. van Smoorenburg S; Kist JM; Vos RC; Vos HMM BMJ Open; 2023 Aug; 13(8):e066198. PubMed ID: 37591646 [TBL] [Abstract][Full Text] [Related]
38. Use of placental vascularization indices and uterine artery peak systolic velocity in early detection of pregnancies complicated by gestational diabetes, chronic or gestational hypertension, and preeclampsia at risk. Altorjay ÁT; Surányi A; Nyári T; Németh G Croat Med J; 2017 Apr; 58(2):161-169. PubMed ID: 28409499 [TBL] [Abstract][Full Text] [Related]
40. Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. Nerenberg KA; Johnson JA; Leung B; Savu A; Ryan EA; Chik CL; Kaul P J Obstet Gynaecol Can; 2013 Nov; 35(11):986-994. PubMed ID: 24246398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]